Compare Viemed Healthcare, Inc. with Similar Stocks
Dashboard
1
High Management Efficiency with a high ROE of 15.81%
2
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 17.50
3
Healthy long term growth as Net Sales has grown by an annual rate of 15.53%
4
Flat results in Mar 26
5
With ROE of 11.42%, it has a very expensive valuation with a 2.52 Price to Book Value
6
High Institutional Holdings at 82.38%
7
Market Beating Performance
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
25.03%
0%
25.03%
6 Months
60.14%
0%
60.14%
1 Year
67.48%
0%
67.48%
2 Years
84.97%
0%
84.97%
3 Years
27.07%
0%
27.07%
4 Years
57.76%
0%
57.76%
5 Years
26.38%
0%
26.38%
Viemed Healthcare, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
15.53%
EBIT Growth (5y)
0.83%
EBIT to Interest (avg)
17.50
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.04
Sales to Capital Employed (avg)
1.61
Tax Ratio
28.83%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
82.38%
ROCE (avg)
19.50%
ROE (avg)
15.81%
Valuation key factors
Factor
Value
P/E Ratio
22
Industry P/E
Price to Book Value
2.52
EV to EBIT
16.36
EV to EBITDA
7.08
EV to Capital Employed
2.52
EV to Sales
1.32
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
15.42%
ROE (Latest)
11.42%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
Bullish
Bullish
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 44 Schemes (22.61%)
Foreign Institutions
Held by 52 Foreign Institutions (7.56%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
75.40
76.20
-1.05%
Operating Profit (PBDIT) excl Other Income
12.30
16.40
-25.00%
Interest
0.30
0.40
-25.00%
Exceptional Items
-0.10
-0.10
Consolidate Net Profit
2.70
5.80
-53.45%
Operating Profit Margin (Excl OI)
62.70%
115.50%
-5.28%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is -1.05% vs 5.98% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is -53.45% vs 61.11% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
270.30
224.30
20.51%
Operating Profit (PBDIT) excl Other Income
50.40
40.30
25.06%
Interest
1.20
0.80
50.00%
Exceptional Items
-1.10
-0.40
-175.00%
Consolidate Net Profit
15.40
11.40
35.09%
Operating Profit Margin (Excl OI)
80.80%
72.90%
0.79%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 20.51% vs 22.57% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 35.09% vs 11.76% in Dec 2024






